Marcus Keep
MK
Marcus Keep
CMO
About
Marcus Keep is the Chief Medical Officer (CMO) at Mitochon Pharmaceuticals, a clinical-stage biotech company focused on developing drugs targeting mitochondria for neurodegenerative diseases. He is also noted as a founder and significant shareholder in companies involved in mitochondrial disease research and drug development, such as Maas Biolab, LLC and formerly Abliva AB (previously NeuroVive Pharmaceutical).
Frequently asked
Who is Marcus Keep?
Marcus Keep is the Chief Medical Officer (CMO) at Mitochon Pharmaceuticals, a clinical-stage biotech company focused on developing drugs targeting mitochondria for neurodegenerative diseases. He is also noted as a founder and significant shareholder in companies involved in mitochondrial disease research and drug development, such as Maas Biolab, LLC and formerly Abliva AB (previously NeuroVive Ph…
What is Marcus Keep's current role?
Marcus Keep is currently CMO.
Comments
No comments yet. Be the first to share your take.
Profile
About Marcus Keep
Marcus Keep is CMO. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.